Dipeptidyl-Peptidase IV Inhibitors
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Dipeptidyl-Peptidase IV Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
    
			
			
				
				
					
						| Descriptor ID | D054873 | 
					
						| MeSH Number(s) | D27.505.519.389.745.335 D27.505.696.422.500 | 
					
						| Concept/Terms | Dipeptidyl-Peptidase IV InhibitorsDipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase IV InhibitorsInhibitors, Dipeptidyl-Peptidase IVGliptinsDipeptidyl-Peptidase 4 InhibitorsDipeptidyl Peptidase 4 Inhibitors
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Dipeptidyl-Peptidase IV Inhibitors".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Dipeptidyl-Peptidase IV Inhibitors".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Dipeptidyl-Peptidase IV Inhibitors" by people in this website by year, and whether "Dipeptidyl-Peptidase IV Inhibitors" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2014 | 1 | 0 | 1 | 
| 2019 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Dipeptidyl-Peptidase IV Inhibitors" by people in Profiles.
						
					
								- 
								Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example. Value Health. 2020 02; 23(2):217-226. 
- 
								Management of a prediabetes case with the DPP-4 inhibitor sitagliptin. Ann Pharmacother. 2014 Jun; 48(6):811-5.